Naloxone does not increase the minimum alveolar anesthetic concentration of sevoflurane in mice

Anesthesia and Analgesia

Volumn 102, Issue 5, 2006, Pages 1452-1455

  Liao, Mark ^a   Laster, Michael J ^a   Eger II, Edmond I ^a,b   Tang, Michael ^a   Sonner, James M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; SEVOFLURANE; SODIUM CHLORIDE;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; IMMOBILIZATION; INHALATION ANESTHESIA; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOUSE; MOUSE STRAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL;

EID: 33646195084     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000204254.87933.f6     Document Type: Article

References (17)

1. Dahan A, Sarton E, Teppema L, et al. Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice. Anesthesiology 2001;94:824-32.
2. Hao S, Takahata O, Mamiya K, Iwasaki H. Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems. Life Sci 2002;71:571-80.
3. Harper MH, Winter PM, Johnson BH, Eger II EI. Naloxone does not antagonize general anesthesia in the rat. Anesthesiology 1978;49:3-5.
4. Pace NL, Wong KC. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog. Anesth Analg 1979;58:36-9.
5. Levine LL, Winter PM, Nemoto EM, et al. Naloxone does not antagonize the analgesic effects of inhalation anesthetics. Anesth Analg 1986;65:330-2.
6. de Wolff MH, Leather HA, Wouters PF. Effects of tramadol on minimum alveolar concentration (MAC) of isoflurane in rats. Br J Anaesth 1999;83:780-3.
7. Mantz J, Azerad J, Limoge A, Desmonts JM. Transcranial electrical stimulation with Limoge's currents decreases halothane requirements in rats: evidence for the involvement of endogenous opioids. Anesthesiology 1992;76:253-60.
8. Segal IS, Vickery RG, Walton JK, et al. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic a-2 adrenergic receptor. Anesthesiology 1988;69:818-23.
9. Tay AA, Tseng CK, Pace NL, et al. Failure of narcotic antagonist to alter electroacupuncture modification of halothane anaesthesia in the dog. Can Anaesth Soc J 1982;29:231-5.
10. Maze M, Vickery R, Merlone S, Gaba D. Anesthetic and hemodynamic effects of the alpha2-adrenergic agonist, azepexole, in isoflurane-anesthetized dogs. Anesthesiology 1988;68:689-94.
11. Michelsen LG, Salmenpera M, Hug Jr., CC, et al. Anesthetic potency of remifentanil in dogs. Anesthesiology 1996;84:865-72.
12. Olofsen E, Dahan A. The dynamic relationship between end-tidal sevoflurane and isoflurane concentrations and bispectral index and spectral edge frequency of the electroencephalogram. Anesthesiology 1999;90:1345-53.
13. Sonner J, Gong D, Li J, et al. Mouse strain modestly influences minimum alveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg 1999;89:1030-4.
14. Sonner JM, Gong D, Eger II EI. Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg 2000;91:720-6.
15. Eger II, EI, Saidman LJ, Brandstater B. Temperature dependence of halothane and cyclopropane anesthesia in dogs: correlation with some theories of anesthetic action. Anesthesiology 1965;26:764-70.
16. Paul M, Fisher DM. Are estimates of MAC reliable? Anesthesiology 2001;95:1362-70.
17. Gerlai R. Gene targeting: technical confounds and potential solutions in behavioral brain research. Behav Brain Res 2001;125:13-21.